Research Article

[Retracted] Bioinformatics Analysis Identifies ASCL1 as the Key Transcription Factor in Hepatocellular Carcinoma Progression

Figure 6

SLC6A13 could be a prognosis biomarker in HCC progression. (a–d) The prognostic value of SLC6A13 in OS, PFS, RFS, and DSS. (e) ROC curve analysis of SLC6A13 in CRC. (f–k) Correlation analysis of the levels of SLC6A13 and clinical parameters of different HCC patients, including T stage, N stage, M stage, G stage, histological subtypes, and TP53 mutation status. .
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)